Navigation Links
VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD
Date:7/1/2009

Hollywood, FL July 1, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced results from a Phase 3b study that found VYVANSE (lisdexamfetamine dimesylate) CII demonstrated significant efficacy at 14 hours after administration during a simulated workplace environment study in adults with Attention Deficit Hyperactivity Disorder (ADHD). VYVANSE is the first approved stimulant for adults with ADHD to be evaluated in this setting, and these data were presented today at the 49th annual New Clinical Drug Evaluation Unit meeting in Hollywood, FL. VYVANSE is currently approved by the US Food and Drug Administration (FDA) for the treatment of ADHD in children age 6 to 12 years and in adults with ADHD.

"Long-acting medication may be important for adults with ADHD because ADHD symptoms, such as inattention, hyperactivity, and impulsivity, may impact them at work, as well as in at least one other area of their life," said Matthew Brams, MD, study author and psychiatrist in private practice with Bayou City Research, Ltd in Houston. "In this study, adults taking VYVANSE demonstrated significant efficacy as measured by the Permanent Product Measure of Performance (PERMP), from two hours, the first time point measured, up to 14 hours following administration. Additionally, adults taking VYVANSE demonstrated significant ADHD symptom improvement, as measured by the ADHD Rating Scale (ADHD-RS) with adult prompts. These findings may be important for adults who require ADHD symptom management at work, at home, and in social settings."

In this study, investigators evaluated adults with ADHD in an adult simulated workplace environment setting. In this setting, adults engaged in tests and activities that require a level of attention needed in many workplace settings. The efficacy of VYVANSE was measured by PERMP, a validated, time sensitive, skill adjusted math test designed to evaluate an adult's ability t
'/>"/>

Contact: Matthew Cabrey (Shire North America)
484-595-8248
Porter Novelli
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
2. VYVANSE provided behavior, inattention and math test score improvements in children with ADHD
3. Phase III pivotal results presented of VYVANSE to treat ADHD in adults
4. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
5. FDA approves additional dosage strengths of Vyvanse
6. Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track
7. VYVANSE trial in adult ADHD demonstrated significant efficacy within 1 week of daily treatment
8. Record Number of Volunteers Provided Free Dental Care to Needy Children in Minnesota
9. Chronic Pain Patients Now Have Hope With Carryover Pain Relief Provided By Repeated Interferential Treatments
10. National Institutes of Health Expands Use of Emergency Notification Services Provided by Send Word Now(TM) Across NIH Campus
11. $5.15 Million Provided to Support Local Health Care Needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... sick children with complex chronic illnesses can receive effective, less ... home," with easy access to a team of dedicated health ... likely to become seriously ill and need either hospitalization or ... at an enhanced medical home clinic at the University of ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- Overeating is common during ... eat in moderation, an expert says. "Don,t arrive at ... calories if you know you,ll be attending a party, but ... Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount Kisco, ... to eat healthy during the day and even to have ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... a "fountain of youth" drug that can delay the effects ... new study suggests. Seniors received a significant boost to ... genetic signaling pathway linked to aging and immune function, researchers ... experimental medication, a version of the drug rapamycin, improved the ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number of ... District of West Virginia, Bernstein Liebhard LLP reports. According ... Court is scheduled to convene a Joint Status Conference ... at 10:00 a.m. Parties have been directed to submit ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Plugin creators ... ProFire 5k. A fully customizable business presentation tool made ... “Adding the ProFire 5k business tool, users can now ... Austin, CEO of Pixel Film Studios. “ProFire 5k gives ... style to add professionalism to a presentation” , Pixel ...
Breaking Medicine News(10 mins):Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... bridge diabetes and obesity research and treatment , ... and Burnham Institute for Medical Research at Lake Nona have ... for medical research. Today, officials from Florida Hospital and Burnham ... R. Smith, an internationally-renowned diabetes and obesity researcher, as the ...
... , MILWAUKEE, Aug. 17 ... the top performing health system in the country in a national ... initiative. This is the second consecutive year that Aurora has ... Demonstration project that involves 250 hospitals from across the country. , ...
... a problem , , MONDAY, Aug. 17 (HealthDay News) -- ... psychologically damaged from merciless teasing, a new study provides reassurance ... exposure to short jokes. , The study, which appears in ... children reported being teased only slightly more than their peers, ...
... , CHICAGO, Aug. 17 Fueled by ... time when melanoma rates are on the upsurge in younger females, ... will offer free skin cancer screenings and sun safety education to ... and the PING Junior Solheim Cup. , , ...
... ... designed to give prospective patients an idea of what the future can hold. Dr. Jack ... surgery in Dallas a view of what they think would look best for that ... , ...
... ... ... largest providers of specialty products and services for the workers, compensation market, today announced that Lori ... excited to have Lori join PMSI in this critical role. She is a natural fit based ...
Cached Medicine News:Health News:Florida Hospital and Burnham Institute Announce New Executive Director and Facility for Clinical Research Institute 2Health News:Florida Hospital and Burnham Institute Announce New Executive Director and Facility for Clinical Research Institute 3Health News:Aurora Health Care Top Performing Health System in National Quality Initiative 2Health News:Aurora Health Care Top Performing Health System in National Quality Initiative 3Health News:Aurora Health Care Top Performing Health System in National Quality Initiative 4Health News:For Short Kids, No Lack of Self-Esteem 2Health News:For Short Kids, No Lack of Self-Esteem 3Health News:Illinois Dermatologists Tee Up for Sun Safety at Two World-Class Golf Championships 2Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 2Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 3Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 4Health News:PMSI Appoints Lori Daugherty as President of Pharmacy Division 2
(Date:12/24/2014)... DALLAS , December 24, 2014 /PRNewswire/ ... Research Report on Global Disposable Syringe Industry ... to its online business intelligence library. ... Global Disposable Syringe Industry is a professional ... Syringe market.  For overview analysis, the report ...
(Date:12/24/2014)... China , Dec. 23, 2014 ... pharmaceutical company that specializes in patented biopharmaceutical, modernized ... pharmaceutical ingredients (API) today announced that the Company ... its Good Manufacturing Practice (GMP) certificate of TPI,s ... Drug Administration,s (CFDA). The public notice period is ...
(Date:12/22/2014)... LAWRENCE, Mass. , Dec. 22, 2014 /PRNewswire/ ... a leading manufacturer of innovative dialysis products, announced ... (FDA) has cleared its System One™ to perform ... sleeping, known as home nocturnal hemodialysis. NxStage,s® System ... cleared by the FDA for this indication. ...
Breaking Medicine Technology:World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3
... Inc.,(NASDAQ: POTP) today reported the upcoming presentation of,preclinical ... American,Association for Cancer Research (AACR) taking place in ... presentations report,on preclinical studies on talabostat's novel mechanism ... are as,follows: , Presentation Date and Time: Monday, ...
... Therapeutics,Inc. announced today that its small molecule portfolio ... and several poster presentations at next week's 2007,Annual ... to be held in Los Angeles, California April ... for presentation at the,"High Impact Late-Breaking Research 1" ...
Cached Medicine Technology:Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 2Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 3Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 4Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 5Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 6
... corrected IOP measurements in the palm of your ... Make your IOP readings more meaningful with ... built-in IOP calculations. The IOPac is ... accurate corneal measurements in a portable platform and ...
Use the Oculus Mesotest II before and after IOL or refractive surgery. Selectable Landolt ring positions. Accurate measurements in four contrast levels, with and without glare, independent of the pup...
... Hightech American Industrial Laboratories, Inc. specializes ... clinical, eyebank and laboratory specular microscopes, ... Fundus camera digital upgrade package. Our ... and image data correlation with rapid ...
... VersaSuite practice management software is ... the business and clinical aspects of ... solution offers support for the financial, ... the eye care professional. Designed as ...
Medicine Products: